Mr. Antoine Flochel was Vice Chairman of the Board of Directors and Director of Ipsen SA since August 30, 2005. He is also Chairman of the Company Compensation Committee and Member of the Strategic Committee. Mr. Flochel is a graduate of Institut d'Etudes Politiques de Paris and holds a degree in Law and a postgraduate degree in Economics from Universite Paris IX Dauphine. He also holds a MS degree in Finance from the London School of Economics. Between 1995 and 2005, he worked for Coopers & Lybrand Corporationrationrate Finance, becoming an Associate of the company in 1998. Mr. Flochel currently holds several other posts, including Director of Mayroy, Director of Beech Tree SA and Manager of Blue Hill Participations SARL, among others.
The company has return on total asset (ROA) of 7.65 % which means that it generated profit of $7.65 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on equity (ROE) of 9.87 % meaning that it generated $9.87 on every $100 dollars invested by stockholders.
The company has accumulated 23.67 M in total debt with debt to equity ratio (D/E) of 0.03 which may suggest the company is not taking enough advantage from borrowing. Ipsen SA has Current Ratio of 1.36 which is within standard range for the sector.
Ipsen S.A. engages in the research, development, manufacture, and sale of pharmaceutical solutions worldwide. Ipsen SA [IPN] is traded on Paris Stock Exchange in France. It is located in , quai Georges GorseBoulogneBillancourt, and employs 4,835 people. Filter other
Click "OK" to permanently delete this portfolio. Click "Cancel" if you have changed your mind.
Report was successfully generated.
You can either (1) right-mouth click the image to download it to your local drive or simply (2) copy and paste the
image data below to include picture of this graph on your web page without downloading the image file
Copy and paste above text right to your web page html
Macroaxis is user-driven community of investors. We appreciate any feedback or comment you can provide.
Please fill out our quick survey to help us provide your with a better service and user experience
Most of the functionality on our site is free to use.
However we do provide premium service to sophisticated investors. Our premium subscription will give you unprecedented
capabilities to optimize your portfolios using robust financial analysis toolkit, fast mean-variance optimization engine, and proven portfolio theory
-0.06% 
Equity Search
Advanced Search
Market Screener
Adviser Directory
Suggest Portfolio
Backtest Watchlist
Analyze Correlations
View Transactions
Check Volatility
Import Equities
Advice
OTC
Frankfurt
Paris
